Melinda Hanes

Melinda Hanes has a strong background in biology and antibody discovery and engineering. Melinda is currently serving as the Director of Biology at Glycoera AG since June 2023. Prior to this role, they held positions at Seeker Biologics, where they were the Director of Antibody Discovery and Engineering from January 2023 to May 2023 and the Associate Director of Antibody Discovery and Engineering from April 2022 to December 2022. Before joining Seeker Biologics, Melinda was a Principal Scientist at TCR² Therapeutics Inc. from December 2020 to May 2022. Melinda also worked as a Senior Scientist at Visterra Inc. from January 2019 to December 2020. Earlier in their career, Melinda held NRSA Postdoctoral Fellow positions at Beth Israel Deaconess Medical Center from September 2015 to January 2019 and Emory University from 2013 to August 2015.

Melinda Hanes completed their education with a Doctor of Philosophy (Ph.D.) in Biophysics from the University of California, Berkeley, starting in 2003 and finishing in 2009. Prior to that, they obtained a Bachelor of Science (BS) degree in Chemistry and Biology from Pennsylvania State University-Erie Campus, studying from 1999 to 2003. It is unclear when they attended CV High School, as the start and end years are not provided, and no degree or field of study is specified for this educational institution.